#pharmaceutical-supply-chain
(20 articles)100 Essential US Medicines Face Hidden Supply Chain Risks
A comprehensive CIDRAP analysis has identified hidden supply chain vulnerabilities affecting approximately 100 essential medicines in the United States. These risks stem from single-source dependencie
US Launches Section 301 Probe Into German Drug Pricing
The U.S. Trade Representative has initiated a Section 301 investigation into Germany's drug pricing policies, alleging that the European nation's regulatory framework unfairly shifts pharmaceutical re
Antwerp-Bruges joins Pharma.Aero, expanding pharma air logistics
The Port of Antwerp-Bruges has achieved a significant milestone by becoming the first seaport to join Pharma.Aero, an aviation industry network focused on improving pharmaceutical supply chain efficie
Airfreight Industry Unprepared for Pharma Surge, DSV Expands
The air cargo industry faces a critical readiness challenge as demand for temperature-sensitive pharmaceutical shipments accelerates. DSV's expansion of its Air ThermoDirect service with a new Luxembo
Lufthansa Cargo Achieves Full IATA CEIV Pharma Certification
Lufthansa Cargo has achieved comprehensive IATA CEIV (Center of Excellence for Independent Validators) Pharma certifications, a significant credential in the pharmaceutical logistics sector. IATA CEIV
Duopharma Diversifies Ingredient Sources to Mitigate Supply Risks
Duopharma, a major Malaysian pharmaceutical manufacturer, is actively pursuing alternative sources for critical pharmaceutical ingredients in response to escalating supply chain risks and market uncer
Trump's Trade Shift Disrupting Pharma Supply Chains
The Trump administration's evolving trade policies are creating structural changes in how pharmaceutical companies source materials and manufacture medications. The shift away from traditional relianc
Geopolitical Risks Threaten Pharma Supply Chains in 2026
DSV's assessment of pharmaceutical supply chain vulnerabilities for 2026 highlights escalating geopolitical tensions as a structural risk to drug manufacturing, ingredient sourcing, and distribution n
Geopolitical Risks Threaten Pharma Supply Chains in 2026
DSV's 2026 outlook identifies significant geopolitical risks emerging across pharmaceutical supply chains, driven by escalating trade tensions, regional conflicts, and regulatory fragmentation. The an
DSV Enhances Thermo Pharma Transport Capabilities
DSV has announced or expanded engagement with Thermo Pharma Transport, reinforcing its position in the specialized pharmaceutical logistics market. This development reflects ongoing industry consolida
Geopolitical Risk Threatens Pharmaceutical Supply Chains in 2026
DSV has identified significant geopolitical risks that are poised to reshape pharmaceutical supply chains throughout 2026. These include trade policy uncertainties, regional tensions, and shifting reg
Early Warning Systems Critical for Reducing Medicine Supply Risks
The Association of the British Pharmaceutical Industry (ABPI) has identified critical gaps in early warning capabilities within the medicines supply chain, highlighting the need for enhanced visibilit
Weather Disasters Threaten US Pharmaceutical Supply Chain
Recent research highlights an emerging structural vulnerability in the US pharmaceutical supply chain: weather-related disasters pose systematic risks to drug distribution networks. Unlike localized s
ABPI Launches Collaborative Initiative to Strengthen UK Medicine Supply Chain
The Association of the British Pharmaceutical Industry (ABPI) has launched a collaborative initiative focused on building resilience within the UK's medicines supply chain. This effort reflects growin
US Drug Supply Exposed: Critical China Dependency Risk
The US pharmaceutical supply chain faces a critical structural vulnerability stemming from significant dependency on China for active pharmaceutical ingredients (APIs) and drug manufacturing. This con
USMCA Strengthens North American Pharmaceutical Manufacturing
The USMCA trade framework presents a significant opportunity for North American pharmaceutical manufacturers to optimize supply chain operations and reduce dependencies on distant suppliers. By levera
Weather Disasters Threaten U.S. Drug Supply Chain Resilience
Research from the American Chemical Society highlights an emerging structural vulnerability in U.S. pharmaceutical supply chains: increasing weather disasters and climate volatility are creating syste
Global Supply Chain Disruptions Worsen US ADHD Drug Shortage
A new report from CIDRAP connects ongoing ADHD drug shortages in the United States directly to broader global supply chain disruptions, signaling that pharmaceutical supply issues extend beyond isolat
U.S. Tariffs Threaten Pharma Supply Chains and Stock Valuations
U.S. tariff and trade policy uncertainty poses material risks to specialty pharmaceutical companies like Intensity Therapeutics, threatening both operational costs and market valuations. Tariff escala
Global Supply Chain Pressures Threaten Drug Availability
Global pharmaceutical supply chains are facing mounting pressures that threaten consistent drug availability across markets. This Expert Q&A article from Pharmacy Times examines the structural and ope